Irazuoncology
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€9—14m (Dealroom.co estimates Dec 2023.)
Baltimore Maryland (HQ)
Authorizing premium user...